Skip to content
Bending the Curve Trial by Trial
?

ROLARR

Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial

N = 471NCT01736072

Population
Patients with rectal adenocarcinoma suitable for curative resection
Design
International randomised clinical trial at 29 sites in 10 countries including 40 surgeons (recruitment January 2011 to September 2014; final follow-up June 2015). Patients with rectal adenocarcinoma suitable for curative resection were randomised to robotic-assisted or conventional laparoscopic resection (high or low anterior resection or abdominoperineal resection). Primary outcome conversion to open laparotomy; secondary end points included complications, circumferential resection margin positivity, quality of life, bladder and sexual dysfunction and oncological outcomes. The paper's registry is ISRCTN80500123.
Primary endpoint
Conversion to open surgery
Arms
  • Conventional laparoscopic surgery (control, n = 234): Conventional laparoscopic rectal cancer resection
  • Robotic-assisted laparoscopic surgery (experimental, n = 237): Robotic-assisted laparoscopic rectal cancer resection
People
Jayne D, senior author Brown J
Δ Conversion to open surgery−4.1 pointsΔ Positive circumferential resection margin−1.2 points
Show the numbers
Results reported for ROLARR
EndpointAnalysisRobotic-assisted laparoscopic surgeryConventional laparoscopic surgeryEffect
Conversion to open surgeryPatients with conversion data (236 robotic-assisted, 230 conventional laparoscopic) of 471 randomisedConversion to open laparotomy (primary outcome)primaryJayne 20178.1%12.2%P=0.1619 of 236 robotic-assisted and 28 of 230 conventional laparoscopic patients; overall conversion rate 10.1%. Unadjusted risk difference 4.1% (95% CI -1.4% to 9.6%); adjusted odds ratio 0.61 (95% CI 0.31 to 1.21). The abstract concludes that robotic assistance did not significantly reduce conversion.
Positive circumferential resection marginPatients with margin data (235 robotic-assisted, 224 conventional laparoscopic)Circumferential resection margin positivity (secondary end point)primaryJayne 20175.1%6.3%P=0.5612 of 235 robotic-assisted and 14 of 224 conventional laparoscopic patients; overall rate 5.7%. Unadjusted risk difference 1.1% (95% CI -3.1% to 5.4%); adjusted odds ratio 0.78 (95% CI 0.35 to 1.76).
Results reported for ROLARR
EndpointAnalysisRobotic-assisted laparoscopic surgeryConventional laparoscopic surgeryEffect
Conversion to open surgeryPatients with conversion data (236 robotic-assisted, 230 conventional laparoscopic) of 471 randomisedConversion to open laparotomy (primary outcome)primaryJayne 20178.1%12.2%P=0.1619 of 236 robotic-assisted and 28 of 230 conventional laparoscopic patients; overall conversion rate 10.1%. Unadjusted risk difference 4.1% (95% CI -1.4% to 9.6%); adjusted odds ratio 0.61 (95% CI 0.31 to 1.21). The abstract concludes that robotic assistance did not significantly reduce conversion.
Positive circumferential resection marginPatients with margin data (235 robotic-assisted, 224 conventional laparoscopic)Circumferential resection margin positivity (secondary end point)primaryJayne 20175.1%6.3%P=0.5612 of 235 robotic-assisted and 14 of 224 conventional laparoscopic patients; overall rate 5.7%. Unadjusted risk difference 1.1% (95% CI -3.1% to 5.4%); adjusted odds ratio 0.78 (95% CI 0.35 to 1.76).
Primary publication: Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017;318(16):1569-1580. PubMedDOI

Appears in

Sources

  1. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017;318(16):1569-1580.

    PubMedDOI